Please join us Monday August 5 for a discussion with Dr. Thomas Holyoke, a professor of political science at Fresno State.
Approximately 86% of Americans believe that their elected officials care more about the “special interests” than themselves. But who are these special interests, and what is it they do to warrant such distrust? In this presentation, Dr. Holyoke provides a systematic overview of the universe of organized interest groups active in Washington, DC, including their types and who they represent. Then he takes a closer look at their different forms of political influence, including trends in how they give campaign contributions in American elections. It ends with a reflection on the prospects for reform, as well as thoughts on a legitimate role interest groups might actually service in a democratic society.
Who: Dr. Thomas Holyoke, Professor of Political Science, California State University, Fresno
When: August 5, 2019 at 7pm
Where: Santa Fe Basque, 3110 N Maroa Ave, Fresno, CA 93704
Please join us on July 8, 2019, for our next edition of Cafe Scientifique, featuring Dr. David Lent from California State University, Fresno.
One of the most commonly used and effective insect repellents is DEET and has been in use, unchanged, for more than 60 years. While DEET is very effective, it is known to be toxic, it has a short window of efficacy, loses its repellency effect over repeated exposure and it does lend itself well to agricultural applications. This research, in part, involves characterizing the effects of DEET analogs on fruit fly behavior and neural pathways to find derivatives that improve on DEET.
Dr. Lent is a neuroethologist with a Ph.D. from The University of Arizona. Currently, he is an Associate Professor in the Department of Biology at Fresno State. He studies the neural basis of behavior in a number of different species with a strong focus on insects.
Who: Dr. David Lent, Department of Biology, Fresno State
When: July 8, 2019, at 7 PM
Where: Santa Fe Basque, 3110 N Maroa Ave, Fresno, CA
Nanotechnology has revolutionized therapy of many diseases but manyapplications of it is coming in cancer. Nanotechnology can be applied not only for cancer treatment but also for detection, prevention, simultaneous diagnosis (theragnostic) and personalized medicine. There are several issues in traditional cancer chemotherapy such as solubility, stability and low selectivity of the agent along with higher side effects, drug resistance, low concentration in tumor leading to treatment failure. Many of these problems can be solved by nanotechnology. The tiny particles can voyage through the patient’s blood, hunting down the diseased cells, penetrate their membrane to deliver precise dose of medicine or appropriate gene. Dr. Hussain and his research team is currently working on the reversal of drug resistance in cancer therapy and combination chemotherapy using multifunctional nanoparticles.
Who: M. Delwar Hussain, M. Pharm., Ph.D., Professor and Interim Chair, Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Health Sciences University
When: June 3, 2019 at 7PM
Where: Santa Fe Basque, 3110 N Maroa Ave., Fresno, CA 93704